Table 5. Current follow-up and vital status for 58 early survivors stratified by aortic dissection.

Variable	All (n=58)	With dissection (n=36)	Without dissection (n=22)
Part of IDE trial	14 (24%)	6 (17%)	8 (36%)
Follow-up within 1 year of repair	58 (100%)	58 (100%)	36 (100%)
Follow-up more than 1 year after repair	32 (55%)	16 (44%)	16 (73%)
Follow-up time from index repair, y	1.2 [0.3–2.5]	1.9 [0.9–6.9]	0.7 [0.3–1.8]
Events of interest
Repair failure	0	0	0
Subsequent aortic rupture	1 (2%)	1 (3%)	0
Subsequent repair	22 (38%)	12 (33%)	10 (46%)
>1 subsequent repair	2 (3%)	0	2 (9%)
Subsequent repairs, by total	n=25	n=12	n=13
Distal (open) – TAAA	12 (48%)	9 (75%)	3 (23%)
Extent I	2 (8%)	1 (8%)	1 (8%)
Extent II	8 (32%)	7 (58%)	1 (8%)
Extent III	1 (4%)	1 (8%)	0
Extent IV	1 (4%)	0	1 (8%)
Endovascular – TEVAR	13 (52%)	3 (25%)	10 (77%)
Type of endograft used during repair
Relay Pro†	n=3	n=2	n=1
Conformable Gore TAG†	n=6	n=1	n=5
Cook Zenith†	n=7	n=1	n=6
Medtronic Valient†	n=1	–	n=1
Late death	10 (17%)	6 (17%)	4 (18%)
Within 1 year	7 (12%)	5 (14%)	2 (9%)
By 5 years	2 (3%)	1 (3%)	1 (5%)
By 10 years	1 (2%)	0	1 (5%)

Values are presented as n (%) or median [quartile 1 – quartile 3]. ^†, more than 1 endograft can be used during endovascular repair. IDE, investigational device exemption; TAAA, thoracoabdominal aortic aneurysm; TEVAR, thoracic endovascular aortic repair.